Healthtech startup Mykare has closed its seed funding round at $3.2 million, including an additional $1 million from Papa.com cofounders Andrew Parker and Alfredo Vaamonde, and a Middle-Eastern family office, the company confirmed. The fresh capital will be used to enhance its AI capabilities, accelerate product development, and expand internationally, cofounder Senu Sam told inc42.com.
Founded in 2022 by Sam, Rahmatulla TM, and Joash Philipose, Mykare initially connected patients with affordable hospitals but pivoted to a B2B model in October 2025. It now offers an AI-native healthcare operating system that automates patient journeys for small and medium hospitals. Its AI agents handle tasks such as identifying patient intent, answering calls with voice AI, booking appointments, managing follow-ups, collecting feedback, and updating CRM records, according to inc42.com.
The startup’s AI platform is embedded in 30-35 larger healthcare facilities, with about 45 more clinics using its services. This funding round follows an earlier $2.2 million raised from OnDeck ODX, Avaana Seed, and others in 2023. Mykare’s focus on automating operational workflows in healthcare aligns with growing demand for AI-driven efficiency in medical services, a sector seeing increased investment globally, inc42.com reported.
Mykare plans to deploy the $3.2 million seed round proceeds to deepen its AI technology and expand its footprint in existing international markets, cofounder Senu Sam stated to inc42.com.